Welcome to SARomics Biostructures

Here we present company news & various activities and discuss how we help customers accelerate their lead discovery projects!

2023 – Another Successful Year

The examples in this post demonstrate some representative projects and company business development activities in 2023. The scientific part shows the applications of the three main areas of our expertise: X-ray crystallography, NMR spectroscopy, and integrated drug discovery.

Read More

Biosimilars: Why is NMR spectroscopy the best method for comparability assessment?

The third article in our series about therapeutic monoclonal antibodies focuses on structural characterization and comparability analysis of biosimilars. We discuss existing evidence that shows that NMR spectroscopy is far superior to other established methods for comparability assessment, like FTIR, UV and circular dichroism (CD) spectroscopy, and differential scanning calorimetry (DSC).

Read More

Antibody structure and engineering: therapeutic monoclonal antibodies

The development of new drugs of biological origin, the majority of which are monoclonal antibodies, is a major focus of modern-day drug design. The information on monoclonal antibody three-dimensional structure, in combination with antibody engineering, plays a central role in this process and has opened the way for the rapidly growing field of monoclöonal antibody therapeutics.

Read More